Outcomes in adult congenital heart disease patients with Down syndrome undergoing cardiac surgery.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
12 Oct 2024
Historique:
received: 18 04 2024
revised: 31 08 2024
accepted: 23 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

As the life expectancy of patients with Down syndrome (DS) improves, the number of older DS patients requiring cardiac surgery for congenital heart disease will increase. Perioperative risk factors and outcomes in these patients are unknown. In a multicenter retrospective study, teenage and adult DS patients undergoing cardiac surgery between 2008-2018 were matched by age and surgical procedure with non-DS patients. Demographic, medical, and surgical characteristics were compared. Outcome measures were length of stay (LOS), duration of mechanical ventilation, need for non-invasive positive pressure ventilation (NIPPV) and reintubation, additional cardiac interventions, postoperative infections, and early postoperative mortality. Risk factors for extended hospital LOS (>10 days) were explored using multivariable logistic regression. We compared 121 DS patients to 121 non-DS patients. DS patients had a longer median LOS (7 vs. 5 days, p<0.001), longer duration of mechanical ventilation (12.5 vs. 6.7 hours, p<0.001), greater need for NIPPV or reintubation (26% vs. 4%, p<0.001), and higher likelihood of postoperative infections (10% vs. 2%, p=0.035). There was no early mortality. Pre-operative risk factors for extended LOS for DS patients included pulmonary medication use (OR 4.0, p=0.046), history of immunodeficiency (OR 10.4, p=0.004), or ≥moderate tricuspid regurgitation (OR 12.7, p<0.001). Teenage and adult DS patients undergoing congenital cardiac surgery had a longer hospital LOS and more postoperative respiratory and infection complications compared to non-DS patients without increased mortality. Cardiac surgery can be performed safely in older DS patients. Management of pulmonary disease, immunodeficiency, and tricuspid regurgitation may mitigate risk.

Sections du résumé

BACKGROUND BACKGROUND
As the life expectancy of patients with Down syndrome (DS) improves, the number of older DS patients requiring cardiac surgery for congenital heart disease will increase. Perioperative risk factors and outcomes in these patients are unknown.
METHODS METHODS
In a multicenter retrospective study, teenage and adult DS patients undergoing cardiac surgery between 2008-2018 were matched by age and surgical procedure with non-DS patients. Demographic, medical, and surgical characteristics were compared. Outcome measures were length of stay (LOS), duration of mechanical ventilation, need for non-invasive positive pressure ventilation (NIPPV) and reintubation, additional cardiac interventions, postoperative infections, and early postoperative mortality. Risk factors for extended hospital LOS (>10 days) were explored using multivariable logistic regression.
RESULTS RESULTS
We compared 121 DS patients to 121 non-DS patients. DS patients had a longer median LOS (7 vs. 5 days, p<0.001), longer duration of mechanical ventilation (12.5 vs. 6.7 hours, p<0.001), greater need for NIPPV or reintubation (26% vs. 4%, p<0.001), and higher likelihood of postoperative infections (10% vs. 2%, p=0.035). There was no early mortality. Pre-operative risk factors for extended LOS for DS patients included pulmonary medication use (OR 4.0, p=0.046), history of immunodeficiency (OR 10.4, p=0.004), or ≥moderate tricuspid regurgitation (OR 12.7, p<0.001).
CONCLUSIONS CONCLUSIONS
Teenage and adult DS patients undergoing congenital cardiac surgery had a longer hospital LOS and more postoperative respiratory and infection complications compared to non-DS patients without increased mortality. Cardiac surgery can be performed safely in older DS patients. Management of pulmonary disease, immunodeficiency, and tricuspid regurgitation may mitigate risk.

Identifiants

pubmed: 39401550
pii: S0003-4975(24)00857-9
doi: 10.1016/j.athoracsur.2024.09.037
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Sarah W Goldberg (SW)

Division of Cardiac Critical Care, Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts,. Electronic address: sarah.goldberg@cardio.chboston.org.

Chereen Chalak (C)

Division of Cardiac Critical Care, Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Brett R Anderson (BR)

Division of Pediatric Cardiology, NewYork-Presbyterian/Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, New York, New York.

Justin Elhoff (J)

Division of Critical Care, Department of Pediatrics, Texas Children's Hospital, Houston, Texas.

Stephanie Gaydos (S)

Division of Pediatric Cardiology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.

Adam M Lubert (AM)

Cincinnati Adult Congenital Heart Disease Program, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Peter Sassalos (P)

Cardiothoracic Surgery, Department of Cardiothoracic Surgery, University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan.

Kimberlee Gauvreau (K)

Biostatistics, Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Michelle Gurvitz (M)

Division of Adult Congenital Heart Disease, Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Classifications MeSH